Literature DB >> 8795365

To preserve or not to preserve, is that the question?

L A Wilson.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8795365      PMCID： PMC505547          DOI： 10.1136/bjo.80.7.583

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  12 in total

1.  Microbial contamination of in-use ocular medications.

Authors:  O D Schein; P L Hibberd; T Starck; A S Baker; K R Kenyon
Journal:  Arch Ophthalmol       Date:  1992-01

2.  Practical suggestions for the preparation and maintenance of sterile ophthalmic solutions.

Authors:  F H THEODORE; R R FEINSTEIN
Journal:  Am J Ophthalmol       Date:  1952-05       Impact factor: 5.258

3.  Infection of the cornea with B. pyocyaneus. Clinical study and summary of ten cases personally observed.

Authors:  J L BIGNELL
Journal:  Br J Ophthalmol       Date:  1951-07       Impact factor: 4.638

4.  The preparation and sterilization of ophthalmic solutions.

Authors:  M J HOGAN
Journal:  Calif Med       Date:  1949-12

5.  Ocular infection caused by Psychrobacter immobilis acquired in the hospital.

Authors:  G A Gini
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 6.  Management of the dry-eye patient.

Authors:  M A Lemp
Journal:  Int Ophthalmol Clin       Date:  1994

7.  The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study.

Authors:  R R Pfister; N Burstein
Journal:  Invest Ophthalmol       Date:  1976-04

8.  [The COMOD system. A preservative-free multidose container for eyedrops].

Authors:  C Teping; B Wiedemann
Journal:  Klin Monbl Augenheilkd       Date:  1994-10       Impact factor: 0.700

9.  The contamination of fluorescein solutions; with special reference to pseudomonas aeruginosa (bacillus pyocyaneus).

Authors:  D G VAUGH
Journal:  Am J Ophthalmol       Date:  1955-01       Impact factor: 5.258

10.  Microbial contamination of medications used to treat glaucoma.

Authors:  O Geyer; E J Bottone; S M Podos; R A Schumer; P A Asbell
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638
View more
  10 in total

1.  Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives.

Authors:  Elmer Y Tu
Journal:  Saudi J Ophthalmol       Date:  2014-06-23

2.  Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

Authors:  P J Pisella; P Pouliquen; C Baudouin
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations.

Authors:  Kuan-Hui Hsu; Karishma Gupta; Harish Nayaka; Aashrit Donthi; Siddarth Kaul; Anuj Chauhan
Journal:  Pharm Res       Date:  2017-10-24       Impact factor: 4.200

4.  Microbial contamination of preservative free eye drops in multiple application containers.

Authors:  M Q Rahman; D Tejwani; J A Wilson; I Butcher; K Ramaesh
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

5.  Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients.

Authors:  Michael B Horsley; Malik Y Kahook
Journal:  Clin Ophthalmol       Date:  2009-06-02

6.  Changes in corneal parameters at confocal microscopy in treated glaucoma patients.

Authors:  Stefano Ranno; Paolo Fogagnolo; Luca Rossetti; Nicola Orzalesi; Paolo Nucci
Journal:  Clin Ophthalmol       Date:  2011-07-26

7.  Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Authors:  Purvi Bhagat; Kalyani Sodimalla; Chandrima Paul; Surinder S Pandav; Ganesh V Raman; Rengappa Ramakrishnan; Abhijeet Joshi; Atul Raut
Journal:  Clin Ophthalmol       Date:  2014-06-28

Review 8.  Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life.

Authors:  Letizia Negri; Antonio Ferreras; Michele Iester
Journal:  J Ophthalmol       Date:  2019-05-02       Impact factor: 1.909

9.  Tolerability in Glaucoma Patients Switched from Preserved to Preservative-Free Prostaglandin-Timolol Combination: A Prospective Real-Life Study.

Authors:  Sonja Jandroković; Sania Vidas Pauk; Dina Lešin Gaćina; Ivan Skegro; Martina Tomić; Sanja Masnec; Tomislav Kuzman; Miro Kalauz
Journal:  Clin Ophthalmol       Date:  2022-09-28

10.  The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study.

Authors:  Sevda Aydin Kurna; Semih Acikgoz; Ahmet Altun; Nurver Ozbay; Tomris Sengor; Osman Okan Olcaysu
Journal:  J Ophthalmol       Date:  2014-06-09       Impact factor: 1.909
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.